ERBB2 and breast cancer: In T47D cells (Fig. S1B) and in JIMT‐1 cells (Fig. S1D), the HER2 RNA expression was reduced to approximately 35% (after 12 days), demonstrating efficient and stable HER2 lentiviral knockdown in both breast cancer cell lines.